Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIRCCa (Cediranib In Recurrent Cervical Cancer)
2009-011542-25Phase 2Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cediranib in Cervical Cancer (CC), cervical squamous cell carcinoma (CSCC) and cervical cancer (mCC) (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Progression-free survival. Started Mar 2010; status: completed.
02
Drugs
cediranib
03
Conditions
Cervical Cancer (CC)cervical squamous cell carcinoma (CSCC)cervical cancer (mCC)
Beyond the preview
Go deeper on 2009-011542-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011542-25.